Streetwise Medical Devices Articles
PAVmed Shares Increase 28% after First US Patient Treated with CarpX Device for Carpal Tunnel Syndrome
Source: Streetwise Reports (2/16/21)
PAVmed Inc. shares reached a new 52-week high after the company reported that the first patient in the U.S. was successfully treated with its CarpX® Device, a minimally invasive carpal tunnel release surgical instrument.
More >
Align Technology Shares Grind 12.5% Higher after Firm Posts Record Q4 Revenue of $834.5 Million
Source: Streetwise Reports (2/4/21)
Align Technology shares set a new 52-week high after the company announced financial results that included record FY/20 total revenues of $2.5 billion.
More >
Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (1/28/21)
Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.
More >
Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (1/15/21)
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereyeâ„¢ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.
More >
Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports (1/13/21)
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.
More >
Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports (11/23/20)
Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm.
More >
Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports (11/6/20)
Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales.
More >
Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue.
More >
Align Technology Shares Head Straight Up on 20.9% Q3 Revenue Growth as Firm Celebrates its 9 Millionth Invisalign Patient
Source: Streetwise Reports (10/22/20)
Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues.
More >
U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports (9/9/20)
The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.
More >
AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports (7/20/20)
Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform.
More >
Analyst: Integrated Model Positioned to Monetize on Telehealth Emergence
Source: Streetwise Reports (7/13/20)
Echelon Capital Markets initiates coverage and explains why it is bullish on CloudMD Software & Services.
More >
Surgical Equipment Firm Delivers Innovative Imaging Systems to Leading Urologists
Source: Streetwise Reports (5/27/20)
Imagin Medical delivered two functional i/Blueâ„¢ Imaging Systems for use in conducting in vivo studies and virtual demonstrations for evaluation by leading urologists.
More >
SmileDirectClub Awarded US Patent for SmileShop Concept and Plans to Reopen Stores in May
Source: Streetwise Reports (4/28/20)
SmileDirectClub shares traded 20% higher after the company reported it has been awarded a U.S. patent for its SmileShop retail concept and treatment process and that it plans to reopen stores on a rolling basis starting in May.
More >
West Pharma Services' Shares Rise 10% on Q1 Sales Growth and Raised FY Earnings Guidance
Source: Streetwise Reports (4/23/20)
Shares of West Pharmaceutical Services traded higher and established a new 52-week high price after the firm reported Q1/20 earnings that included a 10.8% increase in YoY revenues.
More >
CytoSorbents Shares Trade 20% Higher as FDA Grants CytoSorb EUA for COVID-19
Source: Streetwise Reports (4/13/20)
Shares of CytoSorbents traded higher setting a new 52-week intraday high price after the company reported that the FDA granted emergency use authorization for CytoSorb for use in patients with COVID-19.
More >
Inhaled Nitric Oxide Being Tested as COVID-19 Treatment
Source: Streetwise Reports (3/26/20)
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring.
More >
Nemaura Medical Accelerates Launch of sugarBEAT Wearable Continuous Glucose Monitor
Source: Streetwise Reports (2/26/20)
Shares of Nemaura Medical traded 20% higher after the firm reported that it is investigating using its non-invasive continuous glucose monitor sugarBEAT® jointly with its planned health subscription service BEAT®diabetes, to provide personalized lifestyle coaching for people with Type 2 diabetes and prediabetes.
More >
Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance
Source: Streetwise Reports (1/29/20)
Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results.
More >
Imaging System Developer Outlines Plan for 2020
Source: Streetwise Reports (1/24/20)
The company continues to advance its device toward commercialization.
More >
Two Analysts See Company as a Buy for 'Game-Changing' Potential in Bladder Cancer Detection and Surgery
Source: Streetwise Reports (1/14/20)
The disruptive technology is 'poised to deliver significant advancement in bladder cancer detection.'
More >
Transenterix Shares Trade Up 25% on FDA Filing for First Machine Vision System in Robotic Surgery
Source: Streetwise Reports (1/14/20)
Shares of Transenterix opened 50% higher after the company reported that it has submitted a 510(k) submission to the FDA for the first machine vision system for use in robotic surgery.
More >
Developer Completes Design Verification of Imaging Device for Bladder Cancer
Source: Streetwise Reports (1/10/20)
In doing so, it gets one step closer to market approval from U.S. regulators.
More >
Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device
Source: Streetwise Reports (12/31/19)
Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina.
More >
Biotech Advances Imaging Product to Functional Development Phase
Source: Streetwise Reports (12/27/19)
The company aims to conduct pilot production testing in Q1/20.
More >
